|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,207.00 JPY | +1.26% |
|
-0.92% | -2.78% |
| 06-29 | Terumo Interventional Systems Completes First Procedure Using Opuswave Dual Sensor Imaging System in the United States | CI |
| 06-11 | Terumo Corporation - Analyst/Investor Day |
Business description: Terumo Corporation
Number of employees: 30,591
Sales by Activity: Terumo Corporation
| Fiscal Period: March | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) | 2026 (JPY) |
|---|---|---|---|---|---|
Cardiac and Vascular Company | 397B | 481B | 556B | 624B | 676B |
Blood and Cell Technologies Company | 121B | 148B | 168B | 200B | 231B |
Medical Care Solutions Company | 185B | 192B | 198B | 211B | 216B |
Organox | - | - | - | - | 7.98B |
Unallocated Adjustment | 251M | 243M | 248M | 298M | 294M |
Geographical breakdown of sales: Terumo Corporation
| Fiscal Period: March | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) | 2026 (JPY) |
|---|---|---|---|---|---|
United States | 191B | 246B | 280B | 343B | 389B |
Europe | 140B | 160B | 191B | 218B | 243B |
Japan | 206B | 207B | 211B | 217B | 223B |
Asia and Others | 76.99B | 94.28B | 112B | 120B | 132B |
China | 59.35B | 71.95B | 79.41B | 84.97B | 91.31B |
Americas (Excluding United States) | 28.99B | 40.45B | 48.04B | 52.76B | 54.83B |
Executive Committee: Terumo Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Hikaru Samejima
CEO | Chief Executive Officer | 62 | 31/03/2024 |
Jin Hagimoto
DFI | Director of Finance/CFO | - | - |
Shinji Omori
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hiroshi Yagi
COO | Chief Operating Officer | - | - |
| Compliance Officer | 63 | 31/03/2024 |
Composition of the Board of Directors: Terumo Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Toshiaki Takagi
CHM | Chairman | 68 | 31/03/2022 |
Soichiro Uno
BRD | Director/Board Member | 63 | 20/06/2019 |
Hidenori Nishi
BRD | Director/Board Member | 75 | 24/06/2020 |
Keiya Ozawa
BRD | Director/Board Member | 73 | 21/06/2021 |
| Director/Board Member | 64 | 31/05/2021 | |
Hikaru Samejima
BRD | Director/Board Member | 62 | 31/03/2024 |
Toshihiko Nagata
BRD | Director/Board Member | 59 | 31/05/2024 |
| Director/Board Member | 63 | 31/05/2023 | |
Mari Ogiso
BRD | Director/Board Member | 59 | 31/05/2024 |
Keiko Hayashi
BRD | Director/Board Member | 65 | - |
Holdings: Terumo Corporation
| Name | Stocks | % | Valuation |
|---|---|---|---|
TERUMO CORPORATION 0.37% | 5,487,400 | 0.37% | 75 M $ |
CUORIPS INC. 6.41% | 530,000 | 6.41% | 14 M $ |
DAIICHI LIFE GROUP, INC. 0.01% | 279,200 | 0.01% | 3 M $ |
TOHO HOLDINGS CO., LTD. 0.17% | 122,080 | 0.17% | 3 M $ |
| 84,692 | 0.04% | 1 M $ | |
| 140,368 | 0.58% | 781 621 $ | |
| 43,303 | 0.02% | 698 603 $ | |
WIN-PARTNERS CO., LTD. 0.16% | 50,000 | 0.16% | 379 942 $ |
| 72,000 | 0.32% | 353 521 $ | |
| 1,050 | 0.01% | 7 275 $ |
Company details: Terumo Corporation
Group companies: Terumo Corporation
| Name | Category and Sector |
|---|---|
Vascutek Ltd.
 Vascutek Ltd. Miscellaneous Commercial ServicesCommercial Services Designs, produces and distributes products that treat vascular and cardiovascular disease |
Miscellaneous Commercial Services
|
Terumo BCT Europe NV
 Terumo BCT Europe NV Medical SpecialtiesHealth Technology Provides medical services |
Medical Specialties
|
Terumo Europe NV (Belgium) |
Other Medical Equipment, Supplies & Distribution
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.26% | -0.92% | -9.44% | +0.34% | 19.83B | |
| +12.89% | +4.54% | -25.09% | -7.77% | 155B | |
| +4.30% | +0.61% | -7.67% | -4.40% | 103B | |
| +1.16% | -0.50% | +1.05% | +56.63% | 57.7B | |
| -1.11% | +1.09% | +37.83% | +53.63% | 52.27B | |
| +2.70% | +4.60% | -11.49% | -38.52% | 42.68B | |
| +2.98% | -0.97% | - | - | 33.35B | |
| +6.61% | +3.80% | -9.91% | -44.86% | 28.06B | |
| +1.08% | +0.62% | +60.39% | -6.19% | 25.36B | |
| -1.53% | +3.67% | -4.19% | -18.73% | 21.03B | |
| Average | +2.97% | -0.22% | +3.50% | -1.09% | 53.88B | |
| Weighted average by Cap. | +5.16% | -1.81% | -4.28% | +1.91% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4543 Stock
- Company Terumo Corporation
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition